The nonspecific pulmonary function test: Longitudinal follow-up and outcomes

Chest

Volumn 139, Issue 4, 2011, Pages 878-886

  Iyer, Vivek N ^a   Schroeder, Darrell R ^a   Parker, Kenneth O ^a   Hyatt, Robert E ^a   Scanlon, Paul D ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AIRWAY OBSTRUCTION; AIRWAY RESISTANCE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; LUNG ALVEOLUS; LUNG DIFFUSION CAPACITY; LUNG DISEASE; LUNG FUNCTION TEST; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RESTRICTIVE LUNG DISEASE; SPIROMETRY; TOTAL LUNG CAPACITY;

EID: 79953735491     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.10-0804     Document Type: Article

References (16)

1. Hyatt RE S canlon PD, Nakamura M. Interpretation of Pulmonary Function Tests: A Practical Guide. Rochester, MN: Lippincott-Raven; 1997;13-37.
2. Hyatt RE, Cowl CT, Bjoraker JA, Scanlon PD. Conditions associated with an abnormal nonspecific pattern of pulmonary function tests. Chest. 2009;135(2):419-424.
3. Stǎnescu D. Small airways obstruction syndrome. Chest. 1999;116(1):231-233. (Pubitemid 29340287)
4. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948-968. (Pubitemid 41632054)
5. Miller A, Thornton JC, Warshaw R, Anderson H, Teirstein AS, Selikoff IJ. Single breath diffusing capacity in a representative sample of the population of Michigan, a large industrial state. Predicted values, lower limits of normal, and frequencies of abnormality by smoking history. Am Rev Respir Dis. 1983;127(3):270-277.
6. Miller A, Thornton JC, Warshaw R, Bernstein J, Selikoff IJ, Teirstein AS. Mean and instantaneous expiratory flows, FVC and FEV1: prediction equations from a probability sample of Michigan, a large industrial state. Bull Eur Physiopathol Respir. 1986;22(6):589-597. (Pubitemid 17014558)
7. Scanlon PD, Connett JE, Waller LA, Altose MD, Bailey WC, Buist AS. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med. 2000;161(2 pt 1):381-390. (Pubitemid 30129442)
8. Enright PL, Beck KC, Sherrill DL. Repeatability of spirometry in 18,000 adult patients. Am J Respir Crit Care Med. 2004;169(2):235-238. (Pubitemid 38114540)
9. Hyatt RE, Cowl CT, Bjoraker JA, Scanlon PD. Conditions associated with an abnormal nonspecific pattern of pulmonary function tests. Chest. 2009;135(2):419-424.
10. Pelzer AM, Thomson ML. Effect of age, sex, stature, and smoking habits on human airway conductance. J Appl Physiol. 1966;21(2):469-476.
11. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis. 1991;144(5):1202-1218.
12. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC; Official Statement of the European Respiratory Society. Lung volumes and forced ventilatory flows. Report Work ing Party Standardization of Lung Function Tests, European Com munity for Steel and Coal. Eur Respir J Suppl. 1993;16:5-40.
13. Viegi G, Sherrill DL, Carrozzi L, et al. An 8-year follow-up of carbon monoxide diffusing capacity in a general population sample of northern Italy. Chest. 2001;120(1):74-80. (Pubitemid 32744860)
14. Anthonisen NR, Wright EC. Bronchodilator response in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1986;133(5):814-819. (Pubitemid 16116509)
15. Anthonisen NR, Lindgren PG, Tashkin DP, Kanner RE, Scanlon PD, Connett JE; Lung Health Study Research Group. Bronchodilator response in the lung health study over 11 yrs. Eur Respir J. 2005;26(1):45-51.
16. Coates AL, Peslin R, Rodenstein D, Stocks J. Measurement of lung volumes by plethysmography. Eur Respir J. 1997;10(6):1415-1427. (Pubitemid 27278270)